Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
about
Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers.Comparison of hangover effects among triazolam, flunitrazepam and quazepam in healthy subjects: a preliminary reportThe safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practiceThe safety and tolerability of zolpidem--an update.Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers.Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review.A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.Comparative tolerability of newer agents for insomnia.The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.EEG profile of intravenous zolpidem in healthy volunteers.Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
P2860
Q24538579-23751B5E-1968-4FEE-8A0C-38D94FD820ECQ28204735-13D88926-38F9-4A07-83B8-78A72966F292Q28318703-A2248386-127B-4DEF-A03B-5385A3EEA45DQ33604198-82B3F330-B55A-4908-840C-14269EA6E02EQ34156627-FE549F51-DC48-4EED-91FC-7085B1B170D5Q34346372-FA1CE9CE-72E0-4541-B790-0B57343CD85CQ35047546-6E6144CF-8A9F-4047-A0B1-25292DDD0ADBQ36053686-B1B65C88-38C0-4B4D-85EE-23E20E42AEF5Q37577869-42059208-2800-487E-B3E8-EB806A3283F2Q38220445-3A6784E3-C1B4-4E3E-9F8F-70A9D481A4C7Q44931603-435D3C2E-F6DC-42A6-B904-85A54D9C811DQ48852678-3F4F8CC0-7C12-4399-BA79-A4616C7F8081Q48859510-325FD73F-98A0-4F9A-AED2-B2607FD240DEQ48887061-33108CCC-C65E-446F-9FEC-EA3D4594709F
P2860
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Daytime wakefulness following ...... lunitrazepam 2 mg and placebo.
@en
type
label
Daytime wakefulness following ...... lunitrazepam 2 mg and placebo.
@en
prefLabel
Daytime wakefulness following ...... lunitrazepam 2 mg and placebo.
@en
P2093
P2860
P1476
Daytime wakefulness following ...... lunitrazepam 2 mg and placebo.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03798.X
P407
P577
1990-09-01T00:00:00Z